About Synaptonemal complex central element protein 1
Synaptonemal complex central element protein 1 (SYCE1) is a protein
from Homo sapiens identified by UniProt accession
Q8N0S2, 351 residues long.
MolForge cross-references it against 0 known binders and
165 disease associations.
Target properties
| Protein name | Synaptonemal complex central element protein 1 |
| UniProt accession | Q8N0S2 |
| Gene | SYCE1 |
| Organism | Homo sapiens |
| Length | 351 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (165)
Diseases linked to this target (Open Targets).
- spermatogenic failure 15 · score 0.46
- premature ovarian failure 12 · score 0.45
- primary ovarian insufficiency · score 0.44
- male infertility with azoospermia or oligozoospermia due to single gene mutation · score 0.39
- Primary amenorrhea · score 0.32
- head and neck squamous cell carcinoma · score 0.23
- breast adenocarcinoma · score 0.22
- squamous cell lung carcinoma · score 0.10
- gastric adenocarcinoma · score 0.09
- azoospermia · score 0.09
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8N0S2-F1 | alphafold | PREDICTED | 77.52 | — |
Amino-acid sequence (351 residues)
MAGRSLTSKA EPTAGAVDRA EKAGGQDTSS QKIEDLMEMV QKLQKVGSLE PRVEVLINRI NEVQQAKKKA NKDLGEARTI CEALQKELDS LHGEKVHLKE ILSKKQETLR ILRLHCQEKE SEAHRKHTML QECKERISAL NLQIEEEKNK QRQLRLAFEE QLEDLMGQHK DLWDFHMPER LAKEICALDS SKEQLLKEEK LVKATLEDVK HQLCSLCGAE GPSTLDEGLF LRSQEAAATV QLFQEEHRKA EELLAAAAQR HQQLQQKCQQ QQQKRQRLKE ELEKHGMQVP AQAQSTQEEE AGPGDVASPK PLKGERPGAA HQAGPDVLIG QEDTLHPDLS PRGFQEIKEL F
Explore Synaptonemal complex central element protein 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets